Skip to main content

Day: January 6, 2021

Vital Farms to Participate in the 2021 Annual ICR Conference

AUSTIN, Texas, Jan. 06, 2021 (GLOBE NEWSWIRE) — Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced pasture-raised foods nationwide, today announced that Russell Diez-Canseco, President and Chief Executive Officer, and Bo Meissner, Chief Financial Officer, will participate in a fireside chat hosted by Rupesh Parikh, Senior Research Analyst at Oppenheimer & Co., at the 2021 Annual ICR Conference.The discussion will take place on Tuesday, January 12, 2021 at 10:30 a.m. ET, or 9:30 a.m. CT. Participants may access the live webcast under the “Events & Presentations” tab of the Vital Farms Investor Relations site: https://investors.vitalfarms.com/investor-relations. Following the discussion, a replay will be archived on the Company’s Investor Relations site for 90 days.About Vital FarmsContactICRAshley...

Continue reading

Upwork To Present at the 23rd Annual Needham Virtual Growth Conference

SANTA CLARA, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with independent talent, as measured by gross services volume (“GSV”), today announced that President and CEO, Hayden Brown, and Chief Financial Officer, Jeff McCombs, will participate in a fireside chat at the 23rd Annual Needham Virtual Growth Conference. The event will take place on Tuesday, January 12, 2021 at 8:30 a.m. PT/11:30 a.m. ET.An audiocast of the event will be available in the Events and Presentations section of Upwork’s Investor Relations website at investors.upwork.com. An audio webcast archive will be available following the event for approximately 90 days at investors.upwork.com. Please contact the financial institution hosting the conference for additional details. During...

Continue reading

AXT Second Tranche Private Equity Investment in China Largely Complete

FREMONT, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) — AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor substrates, today announced that the second tranche of the private equity investment in its wafer manufacturing company in China, Beijing Tongmei Xtal Technology Co., Ltd. (“Tongmei”), was largely completed in December 2020.   The second tranche investment was originally scheduled to fund in January 2021. In December, seven private equity firms invested approximately $25 million in the second tranche. An additional $1.5 million is expected to be invested in January 2021, closing the second tranche at approximately $26.5 million. The first tranche, totaling approximately $22.5 million, funded in November 2020. Upon the completion of the final $1.5 million investment, the capital raise will total approximately...

Continue reading

ReelTime Quarterly Revenues Increase Nearly 70% Over Previous Period and 25% Over Same Period 2019 Despite Covid Slowdown

Seattle, WA, Jan. 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ReelTime’s revenues from its core business in Q3 2020 have increased by nearly 70% over the previous period and approximately 25% over the same period last year. The revenues reported in the Company’s’ latest financials do not include any revenues from recently acquired Discount Ad Brokers (DAD) a 15-year-old media company operating within a unique niche of the advertising industry. Revenues from this and other completed acquisitions will be included in consolidated reports with the period beginning January 1st, 2021. Annual gross billings for (DAD) have averaged over $20 million per year over the last 3 years resulting in net placement revenues averaging $2.6 million per year.   Net Revenues have historically risen from, 4.2 million in 2018, to 5.1...

Continue reading

Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections

FOSTER CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced the publication of preclinical data for VAX-A1, the Company’s novel Group A Streptococcus (Group A Strep) conjugate vaccine candidate, in the journal Infectious Microbes & Diseases.Group A Strep is one of the leading causes of bacterial infections worldwide, including strep throat and certain severe invasive infections such as sepsis, necrotizing fasciitis and toxic shock syndrome. Strep throat is particularly common in school-age children and a significant source of antibiotic prescriptions globally. The Group A Strep pathogen is also a leading...

Continue reading

Silo Pharma Inc. Receives One Million Dollars in Up Front Licensing Deal for its Psilocybin Cancer Therapeutic Applications in a Combination of Cash and Equities

Englewood Cliffs, NJ, Jan. 06, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that it has entered into an agreement to license technology covered by provisional patent applications filed by Silo Pharma with the United States Patent and Trademark Office in use for patients suffering with cancer. Silo Pharma’s patent applications relates to using a novel peptide with Psilocybin as a therapeutic.Eric Weisblum, CEO of Silo Pharma, Inc, stated “We are excited about this opportunity as we continue to execute our plan to bring novel therapeutics to patients inflicted with neurological disorders and rare diseases, which we hope will bring about breakthroughs that can lead to improved care. This agreement is structured...

Continue reading

Brookline Bancorp, Inc. Announces Fourth Quarter 2020 Earnings Release Date and Conference Call

BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE) — Brookline Bancorp, Inc. (NASDAQ: BRKL) announced today that it will report fourth quarter 2020 earnings at the close of business on Wednesday, January 27, 2021. Management will host a conference call/webcast to review this information at 1:30 PM Eastern Time on Thursday, January 28, 2021. Interested parties may listen to the call and view a copy of the Company’s Earnings Presentation by joining the call via https://services.choruscall.com/links/brkl210128.html. To listen to this call without access to the slides, interested parties may dial 877-504-4120 (United States) or 412-902-6650 (internationally) and ask for the Brookline Bancorp conference call. A recorded playback of the call will be available for one week following the call at 877-344-7529 (United States) or 412-317-0088 (internationally)....

Continue reading

Baristas Munchie Magic Expands to Oregon Delivering Ben & Jerry’s, Snacks, and Hot Food to Customers Downtown Portland

Seattle, WA, Jan. 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Baristas Coffee Company/Munchie Magic (OTC:BCCI) is expanding into Oregon adding to its fifty locations in Washington State delivering Ben & Jerry’s ice cream, snacks, and hot foods to customers via delivery partners DoorDash, GrubHub, and Uber Eats. www.baristas.tv  www.munchiemagic.comThe newest of the rapidly expanding Munchie Magic virtual restaurants that deliver Ben & Jerry’s ice cream, snacks, and hot foods through its third-party delivery partners services the central and surrounding downtown Portland, OR core. Barry Henthorn, CEO, stated: “The success that Munchie Magic has had in WA state is allowing us to expand into other states. Oregon is a natural progression for us as it is close to our other current locations yet gains...

Continue reading

Shattuck Labs to Present at 39th Annual J.P. Morgan Healthcare Conference

AUSTIN, TX and DURHAM, NC, Jan. 06, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will present at the 39th Annual J.P. Morgan Healthcare Conference being held virtually January 11-14, 2021.Presentation DetailsConference: 39th Annual J.P. Morgan Healthcare ConferencePresenter: Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive OfficerDate: January 14, 2021Time: 5:20 p.m. ESTWebcast Link: Available HereThe live webcast of the presentation will be available on the Events & Presentations section of the Company’s website. A replay of the webcast will be archived for up to 30 days following...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.